BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 27, 2008
View Archived Issues
Sangamo's new zinc finger protein transcription factor neuroprotective in spinal injury model
Read More
TMC-435350 well tolerated, with dose-dependent anti-HCV activity in phase II study
Read More
Med Discovery and Laborium Biopharma sign bioprocess development partnership
Read More
Idera and Merck & Co. extend research collaboration for Toll-like receptor agonists
Read More
Novel PGE2 receptor modulators emerge from Astellas R&D
Read More
New immunomodulatory agents disclosed in recent Novartis patent
Read More
Recent GSK patents disclose novel agents for tuberculosis
Read More
FDA accepts for review Labopharm's trazodone NDA for major depressive disorder
Read More
Phylogica to acquire all outstanding shares in subsidiary Dynamic Microbials
Read More
FDA extends review of Somaxon's NDA for insomnia drug Silenor by 3 months
Read More
Emisphere reports results from Novartis Pharma study of PTH-134 using Eligen technology
Read More
Covidien licenses worldwide rights to DepoMed's AcuForm drug delivery technology
Read More
King Pharmaceuticals signs definitive merger agreement with Alpharma
Read More
Transgene's TG-1042 meets primary endpoint in CBCL phase II trial
Read More
Recordati files MAA in Europe for silodosin for benign prostatic hyperplasia
Read More
Schering-Plough reports top-line results for Saphris in schizophrenia
Read More
Genzyme files sNDA for Clolar in adult myeloid leukemia
Read More
Preladenant meets primary endpoint in phase II dose-finding trial in PD
Read More
Advisory committee recommends FDA approval of febuxostat for gout
Read More
Aldose reductase inhibition lowers urinary albumin excretion in type 1 diabetes
Read More
Vascugel safe in phase I/II study in patients with arteriovenous access
Read More
Severity reduction of EAE with new sPLA2 inhibitor peptide
Read More
Lilly completes acquisition of ImClone Systems
Read More
Cephalon and ImmuPharma sign USD 15 million option agreement for Lupuzor for SLE
Read More
Phase I study data on ITMN-191 presented, ITMN-5489 introduced
Read More